Abstract
Objective
To verify possible relations between vocal disability and aerodynamic measures in selected Parkinson’s disease (PD) patients with low/moderate-grade dysphonia.
Methods
Fifteen idiopathic dysphonic PD male patients were examined and compared with 15 euphonic subjects. Testing included the following measures: Voice Handicap Index (VHI), maximum phonation time (MPT), mean estimated subglottal pressure (MESGP), mean sound pressure level (MSPL), mean phonatory power (MPP), mean phonatory efficiency (MPE) and mean phonatory resistance (MPR).
Results
Statistical analysis showed: a significant reduction in MPR and MSPL in PD subjects compared to the healthy ones; a significant positive correlation between VHI score and MSPL, MPR, MPP, MESGP and a significant negative correlation between VHI and MTP within PD subjects. Test for multiple linear regression showed a significant correlation between VHI score, MPT, MPR and MSPL.
Conclusions
A relationship between VHI and aerodynamic measures was shown in the present study. Compensatory mechanisms may aggravate vocal disability in PD subjects.
Similar content being viewed by others
References
Pinto S, Ghio A, Teston B, Viallet F (2010) Dysarthria across Parkinson’s disease progression. Natural history of its components: dysphonia, dysprosody and dysarthria. Revue Neurologique 166(10):800–810
Ciucci MR, Grant LM, Rajamanickam ES, Hilby BL, Blue KV, Jones CA, Kelm-Nelson CA (2013) Early identification and treatment of communication and swallowing deficits in Parkinson disease. Semin Speech Lang 34(3):185–202
Peacher WG (1950) The etiology and differential diagnosis of dysarthria. J Speech Hear Disord 15(3):252–265
Sewall GK, Jiang J, Ford CN (2006) Clinical evaluation of Parkinson’s-related dysphonia. Laryngoscope 116(10):1740–1744
Logemann JA, Fisher HB, Boshes Band B, Blonsky EB (1978) Frequency and cooccurence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Disord 43(1):47–57
Ho AK, Iansek R, Marigliani C, Bradshaw JL, Gates S (1998) Speech impairment in a large sample of patients with Parkinson’s disease. Behav Neurol 11(3):131–137
Harel BT, Cannizzaro MS, Cohen H, Reilly N, Snyder PJ (2004) Acoustic characteristics of parkinsonian speech: a potential biomarker of early disease progression and treatment. J Neurolinguist 17(6):439–453
Rusz J, Cmejla R, Ruzickova H, Ruzicka E (2011) Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson’s disease. J Acoust Soc Am 129(1):350–367
Jiang JJ, Maytag AL (2014) Aerodynamic measures of glottal function: what extra can they tell us and how do they guide management? Curr Opin Otolaryngol Head Neck Surg 22(6):450–454
Ikui Y, Nakamura H, Sano D, Hyakusoku H, Kishida H, Kudo Y, Joki H, Koyano S, Yamauchi A, Takano S, Tayama N, Hirose H, Oridate N, Tanaka F (2015) An aerodynamic study of phonations in patients with Parkinson disease. J Voice 29(3):273–280
Jiang J, O’Mara T, Chen H et al (1999) Aerodynamic measurements of patients with Parkinson’s disease. J Voice 13(4):583–591
Hammer MJ, Barlow SM (2010) Laryngeal somatosensory deficits in Parkinson’s disease: implications for speech respiratory and phonatory control. Exp Brain Res 201(3):401–409
Smitheran J, Hixon T (1981) Clinical method for estimating laryngeal airway resistance during vowel production. J Speech Hear Disord 46(2):138–146
Jiang J, O’Mara T, Conley D, Hanson D (1999) Phonation threshold pressure measurements during phonation by airflow interruption. Laryngoscope 109(3):425–432
Hammer MJ (2013) Aerodynamic assessment of phonatory onset in Parkinson’s disease: evidence of decreased scaling of laryngeal and respiratory control. J Parkinsons Dis 3(2):173–179
Grillo EU, Verdolini K (2008) Evidence for distinguishing pressed, normal, resonant, and breathy voice qualities by laryngeal resistance and vocal efficiency in vocally trained subjects. J Voice 22(5):546–552
Midi I, Dogan M, Koseoglu M, Can G, Sehitoglu MA, Gunal DI (2008) Voice abnormalities and their relation with motor dysfunction in Parkinson’s disease. Acta Neurol Scand 117(1):26–34
Ramig LO, Dromey C (1996) Aerodynamic mechanisms underlying treatment-related changes in vocal intensity in patients with Parkinson’s disease. J Speech Hear Res 39(4):798–807
Jacobson BH, Johnson A, Grywalsky A, Silbergleit A, Jacobson G, Benninger MS, Newman C (1997) The Voice Handicap Index: development and validation. Am J Speech Lang Pathol 6(3):66–70
Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170
Guimaraes I, Cardoso R, Pinto S, Ferreira JJ (2017) The psychometric properties of the Voice Handicap Index in people with Parkinson’s disease. J Voice 31(2):258 e13–e18
Majdinasab F, Karkheiran S, Moradi N, Shahidi GA, Salehi M (2012) Relation between Voice Handicap Index (VHI) and disease severity in Iranian patients with Parkinson’s disease. Med J Islam Repub Iran 26(4):157–163
Gillespie AI, Gooding W, Rosen C, Gartner-Schmidt J (2014) Correlation of VHI-10 to voice laboratory measurements across five common voice disorders. J Voice 28(4):440–448
Hirano M (1981) Clinical examination of voice. Springer, New York
Yanagihara N (1967) Significance of harmonic changes and noise components in hoarseness. J Speech Hear Res 10(3):531–541
Rosenthal AL, Lowell SY, Colton RH (2014) Aerodynamic and acoustic features of vocal effort. J Voice 28(2):144–153
Yu P, Ouaknine M, Revis J, Giovanni A (2001) Objective voice analysis for dysphonic patients: a multiparametric protocol including acoustic and aerodynamic measurements. J Voice 15(4):529–542
Barsties B, De Bodt M (2015) Assessment of voice quality: current state of the art. Auris Nasus Larynx 42(3):183–188
Majdinasab F, Karkheiran S, Soltani M, Moradi N, Shahidi G (2016) Relationship between voice and motor disabilities of Parkinson’s disease. J Voice 30(6):768 e17–e22
Rosen CA, Lee AS, Osborne J, Zullo T, Murry T (2004) Development and validation of the Voice Handicap Index-10. Laryngoscope 114(9):1549–1556
Forti S, Amico M, Zambarbieri A, Ciabatta A, Assi C, Pignataro L, Cantarella G (2014) Validation of the Italian Voice Handicap Index-10. J Voice 28(2):263 e17–e22
Jayakumar T, Savithri SR (2012) Effect of geographical and ethnic variation on Dysphonia Severity Index: a study of Indian population. J Voice 26(1):e11–e16. https://doi.org/10.1016/j.jvoice.2010.05.008
Sackley CM, Smith CH, Rick C, Brady MC, Ives N (2014) Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson’s disease (PD COMM pilot): study protocol for a randomized controlled trial. Trials. https://doi.org/10.1186/1745-6215-15-213
Isshiki N (1964) Regulatory mechanism of voice intensity variation. J Speech Hear Res 7:17–29
Holmberg EB, Hilman RE, Perkell JS (1988) Glottal airflow and transglottal air pressure measurements for male and female speakers in soft, normal, and loud voice. J Acoust Soc Amer 84(2):511–529
Zhang ZJ (2015) Regulation of glottal closure and airflow in a three-dimensional phonation model: implications for vocal intensity control. J Acoust Soc Am 37:898–910
Maier F, Prigatano GP, Kalbe E, Barbe MT, Eggers C, Lewis CJ, Burns RS, Morrone-Strupinsky J, Moguel-Cobos G, Fink GR, Timmermann L (2012) Impaired self-awareness of motor deficits in Parkinson’s disease: association with motor asymmetry and motor phenotypes. Mov Disord 27(11):1443–1447
Clark JP, Adams SG, Dykstra AD, Moodie S, Jog M (2014) Loudness perception and speech intensity control in Parkinson’s disease. J Commun Disord 51:1–12. https://doi.org/10.1016/j.jcomdis.2014.08.001
Herd CP, Tomlinson CL, Deane KH, Brady MC, Smith CH, Sackley CM, Clarke CE (2012) Comparison of speech and language therapy techniques for speech problems in Parkinson’s disease. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD002814
Ramig LO, Fox C, Sapir S (2004) Parkinson’s disease: speech and voice disorders and their treatment with the Lee Silverman voice treatment. Semin Speech Lang 25(2):169–180
Smith ME, Ramig LO, Dromey C, Perez KS, Samandari R (1995) Intensive voice treatment in Parkinson disease: laryngostroboscopic findings. J Voice 9(4):453–459
Wight S, Miller N (2015) Lee Silverman voice treatment for people with Parkinson’s: audit of outcomes in a routine clinic. Int J Lang Commun Disord 50(2):215–225
Skodda S, Grönheit W, Mancinelli N, Schlegel U (2013) Progression of voice and speech impairment in the course of Parkinson’s disease: a longitudinal study. Parkinson’s Dis. https://doi.org/10.1155/2013/389195
Acknowledgements
No funds were received in support of this study.
Author information
Authors and Affiliations
Contributions
All authors state that they all have participated in the conception and design of the work, in the analysis of the data and in writing the manuscript to take public responsibility of it.
Corresponding author
Ethics declarations
Ethical approval (in case animals were involved)
This article does not contain any studies with animals performed by any of the authors.
Ethical approval (in case humans were involved)
All procedures contributing to this work involving human participants comply with the ethical standards of the Institutional Review Board and Institutional Guidelines on human experimentation and with the 2013 revision of the Helsinki Declaration of 1964. The study on which the paper has been based has received full ethical approval by an appropriate Research Ethics Committee. The protocol of the present study has been approved by the Institutional Review Board.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Conflict of interest
This research received no specific grant from any funding agency, commercial or not-for-profit sectors. The authors have no conflict of interest to report.
Rights and permissions
About this article
Cite this article
Motta, S., Cesari, U., Paternoster, M. et al. Aerodynamic findings and Voice Handicap Index in Parkinson’s disease. Eur Arch Otorhinolaryngol 275, 1569–1577 (2018). https://doi.org/10.1007/s00405-018-4967-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-018-4967-7